SEK | Jotup

Bioservo Technologies: Carbonhand sales doubled in Norway

Retrieved on:

Friday, November 3, 2023

Stroke, Patient, DSM-IV codes, MS, SEK, Pharmaceutical industry

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years. Through the public reimbursement system, Carbonhand is prescribed both as an assistive device for use in the home and as an aid to return to work. The new version of Carbonhand launched this year has several improvements that allow more people to use the glove and thereby improve hand function and grip strength.

Key Points:

In Norway, Carbonhand is sold through the distributor Cypromed, and so far this year they have ordered twice as many Carbonhand to Norway compared to the same period last year.
STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years.
So far this year, Bioservo has received orders for 27 Carbonhand at an order value of about SEK 1.8 million.
"As the new version of Carbonhand becomes known to therapists and patients around Norway, we are experiencing increasing demand.

Sandvik completes the acquisition of software supplier esco GmbH

Retrieved on:

Friday, November 3, 2023

Sandvik, Gesellschaft mit beschränkter Haftung, SEK, Acquisition, EBITA, Software, Esco, Sandvik Coromant

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- Sandvik has completed the previously announced acquisition of esco GmbH engineering solutions consulting, a German-based supplier of software for power skiving, an important technology within gear machining.

Key Points:

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- Sandvik has completed the previously announced acquisition of esco GmbH engineering solutions consulting, a German-based supplier of software for power skiving, an important technology within gear machining.
The company will be reported in Sandvik Coromant, a division within Sandvik Manufacturing and Machining Solutions.
Esco, founded in 1993, has around 17 employees and is headquartered in Aachen, Germany.
For further information, contact Louise Tjeder, VP Investor relations, phone: +46 (0) 70782 6374 or Johannes Hellström, Press and Media Relations Manager, phone: +46 (0) 70721 1008.

Bioservo Technologies: Carbonhand sales doubled in Norway

Retrieved on:

Friday, November 3, 2023

Stroke, Patient, DSM-IV codes, MS, SEK, Pharmaceutical industry

STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years. Through the public reimbursement system, Carbonhand is prescribed both as an assistive device for use in the home and as an aid to return to work. The new version of Carbonhand launched this year has several improvements that allow more people to use the glove and thereby improve hand function and grip strength.

Key Points:

In Norway, Carbonhand is sold through the distributor Cypromed, and so far this year they have ordered twice as many Carbonhand to Norway compared to the same period last year.
STOCKHOLM, Nov. 3, 2023 /PRNewswire/ -- In Norway, Carbonhand has been prescribed as a medical device through the public reimbursement system for several years.
So far this year, Bioservo has received orders for 27 Carbonhand at an order value of about SEK 1.8 million.
"As the new version of Carbonhand becomes known to therapists and patients around Norway, we are experiencing increasing demand.

Alfa Laval Capital Markets Day 2023 - Leading the transition

Retrieved on:

Thursday, November 2, 2023

Capital market, Food, SEK, SCDF Marine Division, Marine, Nasdaq Stockholm, B cell, Natural Resources, Investment, Alfa Laval, Food & Water Watch, Renewable energy, Energy

LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Today, 2 November 2023, Alfa Laval hosted its annual Capital Markets Day.

Key Points:

LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Today, 2 November 2023, Alfa Laval hosted its annual Capital Markets Day.
During the Capital Markets Day, Tom Erixon, President and CEO of Alfa Laval, elaborated on the growth strategy based for each of Alfa Laval's three divisions.
The focus for the Energy Division was on the energy transition and it was announced that Alfa Laval is creating a new business unit - BU Electrolyzer and Fuel Cell Technologies - to accelerate the pace of clean energy solutions.
Thereby, Alfa Laval is not only accelerating success for its customers, but also for people and the planet.

Alfa Laval - Capturing the potential in the hydrogen sector

Retrieved on:

Thursday, November 2, 2023

LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Alfa Laval is establishing a new business unit - Business Unit Electrolyzer and Fuel Cell Technologies - with the aim of capturing business opportunities in the hydrogen sector.

Key Points:

LUND, Sweden, Nov. 2, 2023 /PRNewswire/ -- Alfa Laval is establishing a new business unit - Business Unit Electrolyzer and Fuel Cell Technologies - with the aim of capturing business opportunities in the hydrogen sector.
Over the past three years, Alfa Laval has been present in the hydrogen market, pioneering products and solutions in the areas of electrolyzers and fuel cells.
Recognizing the potential, Alfa Laval has decided to establish a new business unit and develop new products and solutions in hydrogen applications in collaboration with industry leaders.
Drawing upon the company's extensive expertise in heat transfer and metallurgy, Alfa Laval is uniquely positioned in the hydrogen economy.

Orexo Q3 2023 Interim Report

Retrieved on:

Thursday, November 2, 2023

Allergy, FDA, Extraordinary general meeting, Opioid overdose, EBITDA, Adrenaline, Novo Holdings A/S, Robin, SEK, Committee, Pharmaceutical industry

UPPSALA, Sweden, Nov. 2, 2023 /PRNewswire/ --

Key Points:

›    EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-repeating clinical trials, SEK 13.3 m (14.3)
›    The first patent issued in the US for OX640, epinephrine rescue medication for allergic reactions
›    OX124, high-dose rescue medication for opioid overdose, refiled with the FDA
›    The MODIA® study didn't meet the primary end-points, but showed high rates of treatment response in both study arms, with no adverse events associated with the use of MODIA
›    Robin Evers elected as board member at the Extraordinary General Meeting.
He replaces Henrik Kjaer Hansen who has announced he will resign.
Kjaer Hansen, has instead been appointed chairman of the Nomination Committee, representing Novo Holdings A/S

Orexo Q3 2023 Interim Report

Retrieved on:

Thursday, November 2, 2023

Allergy, FDA, Extraordinary general meeting, Opioid overdose, EBITDA, Adrenaline, Novo Holdings A/S, Robin, SEK, Committee, Pharmaceutical industry

UPPSALA, Sweden, Nov. 2, 2023 /PRNewswire/ --

Key Points:

›    EBITDA of SEK -9.5 m (-32.4), EBITDA excluding costs for legal processes and external non-repeating clinical trials, SEK 13.3 m (14.3)
›    The first patent issued in the US for OX640, epinephrine rescue medication for allergic reactions
›    OX124, high-dose rescue medication for opioid overdose, refiled with the FDA
›    The MODIA® study didn't meet the primary end-points, but showed high rates of treatment response in both study arms, with no adverse events associated with the use of MODIA
›    Robin Evers elected as board member at the Extraordinary General Meeting.
He replaces Henrik Kjaer Hansen who has announced he will resign.
Kjaer Hansen, has instead been appointed chairman of the Nomination Committee, representing Novo Holdings A/S

Interim report, third quarter 2023: Skanska

Retrieved on:

Wednesday, November 1, 2023

Public affairs, High definition, SEK, Project, Telephone numbers in Hungary, Senior, Commercial property, CFO, EU, Skanska, Gasoline, Cryptocurrency

Revenue for the quarter amounted to SEK 40.3 billion (38.6); adjusted for currency effects, revenue increased 1 percent.

Key Points:

Revenue for the quarter amounted to SEK 40.3 billion (38.6); adjusted for currency effects, revenue increased 1 percent.
Adjusted for currency effects, order bookings quarter over quarter decreased 29 percent.
This is information that Skanska AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.
Magnus Persson, Executive Vice President and CFO, Skanska AB, tel +46 10 448 8900
Jacob Birkeland, Head of Media Relations and Public Affairs, Skanska AB, tel +46 10 449 1957
The following files are available for download:

Research on rural and urban sustainability in Amazonia rewarded with the Volvo Environment Prize 2023

Retrieved on:

Monday, October 30, 2023

GOTHENBURG, Sweden, Oct. 30, 2023 /PRNewswire/ -- The vast Amazon region is central to the global debate on creating a stable climate and maintaining biodiversity. But we cannot deal with sustainability in Amazonia if we do not confront the rural and urban realities in the region of poverty, violence, and the need for economic development. That is the message from Eduardo Brondizio, a Brazilian-born Anthropologist Professor at Indiana University, Bloomington, USA, who is the Volvo Environment Prize laureate in 2023.

Key Points:

But we cannot deal with sustainability in Amazonia if we do not confront the rural and urban realities in the region of poverty, violence, and the need for economic development.
That is the message from Eduardo Brondizio, a Brazilian-born Anthropologist Professor at Indiana University, Bloomington, USA, who is the Volvo Environment Prize laureate in 2023.
He has examined issues of land use, deforestation, climate change and food production — and how they impact indigenous, rural, and urban populations.
Most people know the world's largest rainforest is in Amazonia, but the cities are rarely in the global spotlight.

Reminder: Invitation: Sobi's Q3 2023 report

Retrieved on:

Friday, October 27, 2023

CET, Q&A, SEK, EDT, Nasdaq Stockholm, Swedish Orphan Biovitrum

STOCKHOLM, Sweden, Oct. 27, 2023 /PRNewswire/ -- Investors, analysts, and media are invited to participate in a conference call which will include a presentation of the results and a Q&A session on the same day at 13:00 pm CET, 12:00 pm GMT, and 8:00 am EDT.

Key Points:

Sobi plans to publish its report for the third quarter of 2023 on 30 October 2023 at 08:00 CET.
The presentation can be followed live here or afterwards on sobi.com .
The slides will be made available on sobi.com before the conference call.
For details on how to contact the Sobi Investor Relations Team, please click here .